Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Operating Income (2020 - 2025)

BioAtla (BCAB) has 6 years of Operating Income data on record, last reported at -$13.8 million in Q3 2025.

  • For Q3 2025, Operating Income fell 22.35% year-over-year to -$13.8 million; the TTM value through Sep 2025 reached -$66.3 million, up 23.12%, while the annual FY2024 figure was -$73.9 million, 42.98% up from the prior year.
  • Operating Income reached -$13.8 million in Q3 2025 per BCAB's latest filing, up from -$18.6 million in the prior quarter.
  • Across five years, Operating Income topped out at -$11.3 million in Q3 2024 and bottomed at -$37.2 million in Q2 2023.
  • Average Operating Income over 5 years is -$24.1 million, with a median of -$24.3 million recorded in 2022.
  • Peak YoY movement for Operating Income: plummeted 1594.95% in 2021, then skyrocketed 67.82% in 2024.
  • A 5-year view of Operating Income shows it stood at -$23.5 million in 2021, then decreased by 21.59% to -$28.6 million in 2022, then rose by 0.08% to -$28.5 million in 2023, then soared by 43.08% to -$16.2 million in 2024, then rose by 15.11% to -$13.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were -$13.8 million in Q3 2025, -$18.6 million in Q2 2025, and -$17.6 million in Q1 2025.